| Serial Number | 90560241 |
| Word Mark | MOLECULE TO CURE. FAST. |
| Filing Date | Thursday, March 4, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 11, 2022 |
| Registration Number | 6868780 |
| Registration Date | Tuesday, October 11, 2022 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, July 26, 2022 |
| Goods and Services | Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely, manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely, providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing |
| Description of Mark | The mark consists of a word-stacked stylization comprised of the word "Molecule" on top of the words, "to cure". both of which are on top of the word "Fast". |
| Goods and Services | Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for others, namely, contract packaging services in the nature of merchandise packaging for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials, namely, contract packaging services in the nature of pharmaceutical, biopharmaceutical and clinical supplies and materials packaging for others |
| Goods and Services | Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science, namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the fields of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely, development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely, conducting early evaluations in the field of new pharmaceuticals and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceutical and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely, technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Quotient Sciences Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Party Name | Quotient Sciences Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Party Name | Quotient Sciences Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Ruddington, Nottingham NG116JS GB |
| Event Date | Event Description |
| Tuesday, October 11, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, October 11, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 26, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 21, 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, June 17, 2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, June 13, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 9, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 29, 2022 | ASSIGNED TO LIE |
| Tuesday, April 26, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, September 27, 2021 | ASSIGNED TO EXAMINER |
| Thursday, June 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, March 8, 2021 | NEW APPLICATION ENTERED IN TRAM |